Acclinate Enables Pharma to Increase Health Equity
Acclinate helps achieve diversity in clinical trials via e-DICT, our HIPAA-compliant platform that sources diverse clinical trial participants & #NOWINCLUDED a digital platform for helping minority communities get involved.
FOR IMMEDIATE RELEASE
Birmingham, AL, March 18th, 2022— Acclinate is a pioneer in clinical trials technology. The company integrates culture and technology to achieve more inclusive clinical research.
The sole objective of Acclinate is to improve health equity through inclusive research.
“We help pharmaceutical companies, CROs, and healthcare organizations access and engage communities of color, so their research efforts are more inclusive and reflect the populations they serve,” said CEO and co-founder of Acclinate, Del Smith.
Acclinate’s e-DICT platform uses predictive analytics and machine learning to assess who to ask, when to ask, and how to engage for clinical trial participation. Researchers use e-DICT to view aggregated, de-identified data on potential participants matching their inclusion/exclusion criteria, ensuring their trial is presented to eligible candidates most likely to participate. e-DICT provides real-time reports showing awareness, engagement, and participation activity associated with a trial.
To benefit pharma/healthcare organizations, e-DICT provides access to insights gathered from Acclinate’s engagement with communities of color.
e-DICT is the foundation for #NOWINCLUDED, Acclinate’s digital health platform that engages and educates communities of color, enabling participants to make informed decisions on health-related issues. #NOWINCLUDED builds community by sharing perspectives, stories, and insights and supporting individuals across their health journey.
“What Acclinate is doing is exciting, and I think it is going to make a serious impact on the industry,” remarked one researcher.
Diversity in clinical trials helps researchers understand more about a broader population of people.
“Relationships drive trust, and the key to diversity is inclusion. We strive to include minorities in conversations, not as a statistic, as a human being,” said Tiffany Whitlow, co-founder of Acclinate.
The website is streamlined and easy to navigate. It is divided into sections for pharma and CROs, an area for healthcare organizations, and an informative blog.
The blog posts include articles on e-DICT, Acclinate, and other posts related to clinical trial diversity. You can also keep up with the latest news regarding Acclinate there.
The future of clinical trials is here, and Acclinate is leading the way for a better tomorrow.
The team is excited to hear from you! Fill out an inquiry form on the company website to start a conversation about your health awareness efforts today!
About Acclinate: Acclinate helps achieve diversity in clinical trials via e-DICT, our HIPAA-compliant platform that sources diverse clinical trial participants & #NOWINCLUDED a digital platform that educates & engages various individuals on important health decisions. Achieve More Diversity in Clinical Trials.
Acclinate, 1143 1st Avenue South Suite 114 Birmingham, AL 35233
Originally posted On: https://syndication.cloud/acclinate-enables-pharma-to-increase-health-equity/